 REDWOOD CITY, Calif., Nov. 23, 2020 GLOBE NEWSWIRE -- Adverum Biotechnologies, Inc. Nasdaq: ADVM, a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the companys presentation at the Piper Sandler 32nd Annual Virtual Healthcare Conference. 